AIRLINK 74.85 Increased By ▲ 1.15 (1.56%)
BOP 4.90 No Change ▼ 0.00 (0%)
CNERGY 4.39 Decreased By ▼ -0.13 (-2.88%)
DFML 41.80 Decreased By ▼ -3.08 (-6.86%)
DGKC 84.50 Decreased By ▼ -1.00 (-1.17%)
FCCL 21.70 Increased By ▲ 0.30 (1.4%)
FFBL 32.22 Decreased By ▼ -0.29 (-0.89%)
FFL 9.41 Decreased By ▼ -0.18 (-1.88%)
GGL 10.08 Decreased By ▼ -0.19 (-1.85%)
HASCOL 6.91 Decreased By ▼ -0.22 (-3.09%)
HBL 114.30 Decreased By ▼ -0.40 (-0.35%)
HUBC 139.25 Increased By ▲ 0.15 (0.11%)
HUMNL 12.05 Decreased By ▼ -0.37 (-2.98%)
KEL 4.94 Decreased By ▼ -0.09 (-1.79%)
KOSM 4.38 Decreased By ▼ -0.07 (-1.57%)
MLCF 37.83 Increased By ▲ 0.23 (0.61%)
OGDC 132.80 Decreased By ▼ -4.00 (-2.92%)
PAEL 24.98 Decreased By ▼ -0.41 (-1.61%)
PIBTL 6.60 Decreased By ▼ -0.09 (-1.35%)
PPL 118.15 Decreased By ▼ -2.85 (-2.36%)
PRL 26.08 Decreased By ▼ -0.51 (-1.92%)
PTC 13.73 Decreased By ▼ -0.37 (-2.62%)
SEARL 57.60 Increased By ▲ 0.30 (0.52%)
SNGP 66.50 Decreased By ▼ -1.50 (-2.21%)
SSGC 10.29 Decreased By ▼ -0.13 (-1.25%)
TELE 8.28 Decreased By ▼ -0.17 (-2.01%)
TPLP 10.78 Decreased By ▼ -0.20 (-1.82%)
TRG 62.38 Decreased By ▼ -0.96 (-1.52%)
UNITY 26.99 Decreased By ▼ -0.06 (-0.22%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 7,872 Decreased By -68.4 (-0.86%)
BR30 25,333 Decreased By -314.8 (-1.23%)
KSE100 75,010 Decreased By -507.8 (-0.67%)
KSE30 24,071 Decreased By -206.5 (-0.85%)
Editorials

Gene-editing tech could make people immune to flu, HIV in future

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology
Published February 16, 2019 Updated February 18, 2019

Vaccines for viral infections like flu are difficult to develop, but thanks to new emerging gene-editing technology, people could soon go immune to flu or even HIV.

Researchers at the Fred Hutchinson Cancer Research Center have developed a new technique for artificially creating advanced and longer-lasting antibodies by gene-editing the DNA of B cells – immune systems white blood cells responsible for creating antibodies.

As per Futurism, several traditional antibody treatments are only effective for a short time period; antibodies tend to break down rapidly, later requiring additional injections. According to scientists, their technique can ultimately allow doctors to overcome this hurdle since the new antibodies would only need to be injected once.

Chinese scientists clone gene-edited monkeys for disease research

The research published in the journal bioRxiv described that initial tests involved 15 mice and showed promising results, providing 82 days of protection against the respiratory syncytial virus (RSV) – a respiratory tract infection that can prove dangerous for children and adults both.

Moreover, according to New Scientist, despite gene-editing being a rapidly growing trend, scientists still need to prove the technique completely safe, which might take few years. But, according to the research, if the technology ever becomes treatment for humans in future, ‘thousands of hospital visits, disabilities, and death could be prevented each year’.

Copyright Business Recorder, 2019

Comments

Comments are closed.